CN
Biological Medicine and Healthcare Technologies

The area has a cluster of biological medicine companies, mainly focusing on bioengineering, medicine preparation industry and new drug R&D industry. There are 26 biopharmaceutical enterprises in the Zone, and the total output value in 2016 was 14 billion 950 million yuan. The Zone has gathered companies in pharmaceutical raw materials, intermediates and polymer composite materials production, pharmaceutical research and development such as Zhejiang Guobang Pharmaceutical Co. Ltd., Zhejiang NHU Co. Ltd.  and Zhejiang Jingxin Pharmaceutical Co. Ltd.

Focus will also be to develop a cluster of companies working with healthcare technologies to hospitals, healthcare clinics and eldery care.